Sign In

Elisabeth Leiderman

Elisabeth Leiderman is a highly accomplished professional with a diverse educational background and extensive experience in finance, healthcare management, and biotechnology.

She holds a Master of Business Administration (MBA) degree with a concentration in Finance and Healthcare Management from the prestigious University of Pennsylvania - The Wharton School, showcasing her strong acumen in both business and healthcare sectors.

Elisabeth also holds a Medical Doctor (MD) degree from Tel Aviv University Medical School, emphasizing her deep understanding of the medical field, and a Bachelor of Arts (BA) in Biological Sciences from the University of Pennsylvania, reflecting her commitment to biological research.

Currently, Elisabeth Leiderman serves as the Chief Financial Officer & Head of Corporate Development at Decibel Therapeutics, where she leverages her financial expertise to drive strategic decision-making and corporate growth within the biotechnology industry.

Previously, she was recognized as an Executive Women in Bio 2019 Board Room Ready Member at Women In Bio, highlighting her dedication to empowering and advancing women in the life sciences sector through leadership roles and advocacy.

Elisabeth's unique combination of educational achievements and executive positions underscores her as a notable figure in the intersection of finance, healthcare, and biotechnology, contributing significantly to the advancement of these fields.

E
Add to my network

Location

New York, New York